Associated Papers
Routine sequencing of BRAF exon 15 improves therapeutic stratification for metastatic melanoma.
Chen YF et al.
American Journal of Clinical Pathology, 2025
Frequency of targetable genetic alterations in resectable lung adenocarcinoma: Results from the LORD project.
Bossé Y et al.
Lung Cancer (amsterdam, Netherlands), 2025
Prenatal and infantile diagnosis of craniosynostosis in individuals with RASopathies.
Serbinski CR et al.
American Journal of Medical Genetics. Part A, 2024
Exploring the clinical complexity of cardio-facio-cutaneous syndrome: insights from a pediatric case series.
Ou Y et al.
Frontiers in Pediatrics, 2024
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy.
Porcelli L et al.
Pharmacological Research, 2022
Craniosynostosis is a feature of Costello syndrome.
Weaver KN et al.
American Journal of Medical Genetics. Part A, 2022
Acetylation-dependent regulation of BRAF oncogenic function.
Dai X et al.
Cell Reports, 2022
Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders.
Zhang Y et al.
Molecular Neurobiology, 2021
High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens.
Cheng LY et al.
Scientific Reports, 2021
Mutation and Phenotypic Spectrum of Patients With RASopathies.
Lallar M et al.
Indian Pediatrics, 2021
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.
Wang T et al.
Nature Communications, 2020
Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAF.
Seto K et al.
Pathology International, 2020
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report.
Consoli F et al.
Frontiers in Oncology, 2020
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach.
Manca A et al.
Journal of Translational Medicine, 2019
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M et al.
Bmc Cancer, 2019
VIII World Rett Syndrome Congress & Symposium of rare diseases, Kazan, Russia.
Iourov IY et al.
Molecular Cytogenetics, 2018
Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
Ueda K et al.
American Journal of Medical Genetics. Part A, 2017
Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.
Gaiser MR et al.
Plos One, 2017
Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Wei S et al.
Cancer Cytopathology, 2016
Postzygotic BRAF p.Lys601Asn Mutation in Phacomatosis Pigmentokeratotica with Woolly Hair Nevus and Focal Cortical Dysplasia.
Kuentz P et al.
The Journal of Investigative Dermatology, 2016
Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
Han PA et al.
Thyroid : Official Journal of the American Thyroid Association, 2016
The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF.
Kiel C et al.
Elife, 2016
Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.
Tissot C et al.
Lung Cancer (amsterdam, Netherlands), 2016
Bioinformatics Approach for Prediction of Functional Coding/Noncoding Simple Polymorphisms (SNPs/Indels) in Human BRAF Gene.
Hassan MM et al.
Advances in Bioinformatics, 2016
Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.
Dudley JC et al.
Molecular Diagnosis & Therapy, 2014
BRAF pyrosequencing analysis aided by a lookup table.
Olson MT et al.
American Journal of Clinical Pathology, 2014
Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.
Lepri FR et al.
Bmc Medical Genetics, 2014
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.
Li C et al.
The Journal of Clinical Endocrinology and Metabolism, 2013
Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).
Skorokhod A et al.
Plos One, 2013
Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
Indsto JO et al.
Journal of Cutaneous Pathology, 2007